Ourlyard™ Ruxolitinib Cream 1.5%

$15.37$49.11

Ourlyard™ Ruxolitinib Cream 1.5%

Ourlyard™ Ruxolitinib Cream 1.5%

Uses:

  Non-segmental vitiligo 

– Mild or moderate atopic dermatitis 

– Improves skin pigmentation in vitiligo and reduces inflammation in atopic dermatitis.

– Helps restore color to affected areas and relieves symptoms such as itching and redness. 

– By effectively managing these conditions, it reduces the need for other treatments.

Safety information

– Ourlyard™ is intended for use on the skin only. 

– Do not use Ourlyard™ in your eyes, mouth or vagina.

description

Ourlyard™ contains ruxolitinib, a selective Janus kinase (JAK) inhibitor. This topical cream is designed to treat specific dermatological conditions such as non-segmental vitiligo and mild to moderate atopic dermatitis. Each batch of Ourlyard™ is carefully crafted to ensure consistency and effectiveness. Ruxolitinib works by modulating the body’s immune response, reducing inflammation, and promoting skin repigmentation. It is especially effective for patients who do not respond well to other topical treatments or for whom these treatments are not recommended. Key Ingredients: Ruxolitinib: A potent JAK1/JAK2 inhibitor that plays an important role in controlling inflammatory reactions and helping to restore skin pigmentation. Emollients: To moisturize and improve skin texture. Stabilizers: Provides consistency and stability of the cream for effective application. 

Why choose Ourlyard™

Ourlyard™ is specially formulated for the targeted treatment of atopic dermatitis and vitiligo, providing relief of symptoms such as itching, redness and skin depigmentation. Its unique mechanism of action enables effective management of these conditions with fewer side effects than systemic treatments. Topical application of Ourlyard™ allows direct action on affected areas, offering rapid relief and improvement in skin condition. This precise treatment minimizes the risk of systemic side effects usually associated with oral JAK inhibitors. Choose Ourlyard™ for a scientifically supported, clinically proven solution to manage challenging dermatological conditions with the convenience and targeted action of a topical cream. 

YOU CAN FEEL COMFORTABLE

Ourlyard™  is a prescription medicine used on the skin (topically):

  • Short-term and non-persistent chronic treatment of mild to moderate eczema (atopic dermatitis) in immunocompromised adults and children 12 years of age and older, when the disease is not well controlled by topical prescription treatments or when these treatments are not recommended

Use of  Ourlyard™  with other JAK inhibitors or potent immunosuppressants such as azathioprine or cyclosporine is not recommended.

Usage

Ourlyard™  is a prescription medicine used on the skin (topically):

  • Short-term and non-persistent chronic treatment of mild to moderate eczema (atopic dermatitis) in immunocompromised adults and children 12 years of age and older, when the disease is not well controlled by topical prescription treatments or when these treatments are not recommended
  • treatment of a type of vitiligo called non-segmental vitiligo in adults and children over 12 years of age

Use of  Ourlyard™  with other JAK inhibitors or potent immunosuppressants such as azathioprine or cyclosporine is not recommended.

Ourlyard™ Ruxolitinib Cream 1.5%

SKU: 82386 Categories: ,